Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Threshold Isocontouring on High b-Value Diffusion-Weighted Images in Magnetic Resonance Mammography.

Zong F, Bickelhaupt S, Kuder TA, Lederer W, Daniel H, Stieber A, Schlemmer HP, Galvosas P, Laun FB.

J Comput Assist Tomogr. 2019 May 6. doi: 10.1097/RCT.0000000000000868. [Epub ahead of print]

PMID:
31082982
2.

Threshold Isocontouring on High b-Value Diffusion-Weighted Images in Magnetic Resonance Mammography.

Zong F, Bickelhaupt S, Kuder TA, Lederer W, Daniel H, Stieber A, Schlemmer HP, Galvosas P, Laun FB.

J Comput Assist Tomogr. 2019 May/Jun;43(3):434-442. doi: 10.1097/RCT.0000000000000868.

PMID:
31082949
3.

Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.

Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC, Trojanowski JQ, Lee VM.

Nature. 2018 May;557(7706):558-563. doi: 10.1038/s41586-018-0104-4. Epub 2018 May 9.

4.

Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis.

Schaefgen B, Heil J, Barr RG, Radicke M, Harcos A, Gomez C, Stieber A, Hennigs A, von Au A, Spratte J, Rauch G, Rom J, Schütz F, Sohn C, Golatta M.

Eur Radiol. 2018 Jun;28(6):2499-2506. doi: 10.1007/s00330-017-5235-8. Epub 2018 Jan 4.

PMID:
29302784
5.

Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.

He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, Zhang B, Gathagan RJ, Yue C, Dengler C, Stieber A, Nitla M, Coulter DA, Abel T, Brunden KR, Trojanowski JQ, Lee VM.

Nat Med. 2018 Jan;24(1):29-38. doi: 10.1038/nm.4443. Epub 2017 Dec 4.

6.

Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.

Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV, He Z, Zhang B, Gathagan RJ, Trojanowski JQ, Lee VMY.

J Neurosci. 2017 Nov 22;37(47):11406-11423. doi: 10.1523/JNEUROSCI.1230-17.2017. Epub 2017 Oct 20.

7.

Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography.

Bickelhaupt S, Paech D, Laun FB, Steudle F, Kuder TA, Mlynarska A, Bach M, Lederer W, Teiner S, Schneider S, Ladd ME, Daniel H, Stieber A, Kopp-Schneider A, Delorme S, Schlemmer HP.

Clin Radiol. 2017 Oct;72(10):900.e1-900.e8. doi: 10.1016/j.crad.2017.05.017. Epub 2017 Jul 4.

PMID:
28687167
8.

Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?

Heil J, Schaefgen B, Sinn P, Richter H, Harcos A, Gomez C, Stieber A, Hennigs A, Rauch G, Schuetz F, Sohn C, Schneeweiss A, Golatta M.

Eur J Cancer. 2016 Dec;69:142-150. doi: 10.1016/j.ejca.2016.09.034. Epub 2016 Nov 4.

PMID:
27821317
9.

Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.

Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B, Gathagan RJ, Iba M, McBride JD, Trojanowski JQ, Lee VM.

J Exp Med. 2016 Nov 14;213(12):2635-2654. Epub 2016 Oct 17.

10.

Detection and Removal of Ceramic Clip Markers from Breast Tissue by Ultrasound-Guided, Vacuum-Assisted Minimally Invasive Biopsy in a Turkey Breast Model.

Schaefgen B, Heil J, Richter H, Harcos A, Gomez C, Stieber A, Sohn C, Golatta M.

Ultrasound Med Biol. 2017 Jan;43(1):341-345. doi: 10.1016/j.ultrasmedbio.2016.08.024. Epub 2016 Sep 29.

PMID:
27692873
11.

Progression of motor neuron disease is accelerated and the ability to recover is compromised with advanced age in rNLS8 mice.

Spiller KJ, Restrepo CR, Khan T, Stieber AM, Kwong LK, Trojanowski JQ, Lee VM.

Acta Neuropathol Commun. 2016 Sep 29;4(1):105.

12.

Applicability and discriminative value of a semiautomatic three-dimensional spherical volume for the assessment of the apparent diffusion coefficient in suspicious breast lesions-feasibility study.

Hering J, Laun FB, Lederer W, Daniel H, Kuder TA, Stieber A, Delorme S, Maier-Hein KH, Schlemmer HP, Bickelhaupt S.

Clin Imaging. 2016 Nov - Dec;40(6):1280-1285. doi: 10.1016/j.clinimag.2016.08.022. Epub 2016 Sep 4.

PMID:
27684995
13.

Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.

Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marmé F, Jäger D, Kauczor HU, Stieber A, Lindel K, Debus J, Golatta M, Schütz F, Sohn C, Heil J, Schneeweiss A.

BMC Cancer. 2016 Sep 15;16(1):734. doi: 10.1186/s12885-016-2766-3.

14.

Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.

Spiller KJ, Cheung CJ, Restrepo CR, Kwong LK, Stieber AM, Trojanowski JQ, Lee VM.

J Neurosci. 2016 Jul 20;36(29):7707-17. doi: 10.1523/JNEUROSCI.1457-16.2016.

15.

Independent value of image fusion in unenhanced breast MRI using diffusion-weighted and morphological T2-weighted images for lesion characterization in patients with recently detected BI-RADS 4/5 x-ray mammography findings.

Bickelhaupt S, Tesdorff J, Laun FB, Kuder TA, Lederer W, Teiner S, Maier-Hein K, Daniel H, Stieber A, Delorme S, Schlemmer HP.

Eur Radiol. 2017 Feb;27(2):562-569. doi: 10.1007/s00330-016-4400-9. Epub 2016 May 18.

PMID:
27193776
16.

Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?

Schaefgen B, Mati M, Sinn HP, Golatta M, Stieber A, Rauch G, Hennigs A, Richter H, Domschke C, Schuetz F, Sohn C, Schneeweiss A, Heil J.

Ann Surg Oncol. 2016 Mar;23(3):789-95. doi: 10.1245/s10434-015-4918-0. Epub 2015 Oct 14.

PMID:
26467456
17.

Fast and Noninvasive Characterization of Suspicious Lesions Detected at Breast Cancer X-Ray Screening: Capability of Diffusion-weighted MR Imaging with MIPs.

Bickelhaupt S, Laun FB, Tesdorff J, Lederer W, Daniel H, Stieber A, Delorme S, Schlemmer HP.

Radiology. 2016 Mar;278(3):689-97. doi: 10.1148/radiol.2015150425. Epub 2015 Sep 29.

PMID:
26418516
18.

Evaluation of virtual touch tissue imaging quantification, a new shear wave velocity imaging method, for breast lesion assessment by ultrasound.

Golatta M, Schweitzer-Martin M, Harcos A, Schott S, Gomez C, Stieber A, Rauch G, Domschke C, Rom J, Schütz F, Sohn C, Heil J.

Biomed Res Int. 2014;2014:960262. doi: 10.1155/2014/960262. Epub 2014 Mar 31.

19.

Distinct α-synuclein strains differentially promote tau inclusions in neurons.

Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM.

Cell. 2013 Jul 3;154(1):103-17. doi: 10.1016/j.cell.2013.05.057.

20.

TDP-43 skeins show properties of amyloid in a subset of ALS cases.

Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, Lee VM, Trojanowski JQ.

Acta Neuropathol. 2013 Jan;125(1):121-31. doi: 10.1007/s00401-012-1055-8. Epub 2012 Nov 3.

21.

Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM.

Neuron. 2011 Oct 6;72(1):57-71. doi: 10.1016/j.neuron.2011.08.033.

22.

Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.

Luk KC, Song C, O'Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20051-6. doi: 10.1073/pnas.0908005106. Epub 2009 Nov 5.

23.

Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?

Smallwood GA, Devine R, Fasola C, Stieber AC, Heffron TG.

Transplantation. 2008 Dec 27;86(12):1795-8. doi: 10.1097/TP.0b013e3181914188.

PMID:
19104424
24.

Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae.

Soper JH, Roy S, Stieber A, Lee E, Wilson RB, Trojanowski JQ, Burd CG, Lee VM.

Mol Biol Cell. 2008 Mar;19(3):1093-103. doi: 10.1091/mbc.E07-08-0827. Epub 2008 Jan 2. Erratum in: Mol Biol Cell. 2008 May;19(5):2348.

25.

Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.

Rodriguez J, Casper K, Smallwood G, Stieber A, Fasola C, Lehneman J, Heffron T.

Liver Transpl. 2007 Oct;13(10):1396-400.

26.

TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR.

Am J Pathol. 2007 Jul;171(1):227-40.

27.

Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death.

Gonatas NK, Stieber A, Gonatas JO.

J Neurol Sci. 2006 Jul 15;246(1-2):21-30. Epub 2006 Mar 20. Review.

PMID:
16545397
28.

Effect of ubiquitin expression on neuropathogenesis in a mouse model of familial amyotrophic lateral sclerosis.

Gilchrist CA, Gray DA, Stieber A, Gonatas NK, Kopito RR.

Neuropathol Appl Neurobiol. 2005 Feb;31(1):20-33.

PMID:
15634228
29.
30.
31.

Duct-to-duct biliary anastomosis for patients with sclerosing cholangitis undergoing liver transplantation.

Heffron TG, Smallwood GA, Ramcharan T, Davis L, Connor K, Martinez E, Stieber AC.

Transplant Proc. 2003 Dec;35(8):3006-7.

PMID:
14697962
32.

Nonresponders of interferon/ribavirin treatment for recurrent hepatitis C following liver transplantation.

Smallwood GA, Davis L, Connor K, Martinez E, Stieber AC, Heffron TG.

Transplant Proc. 2003 Jun;35(4):1476-7.

PMID:
12826197
33.

Adult and pediatric liver transplantation for autoimmune hepatitis.

Heffron TG, Smallwood GA, Oakley B, Pillen T, Welch D, Connor K, Martinez E, Romero R, Stieber AC.

Transplant Proc. 2003 Jun;35(4):1435-6.

PMID:
12826182
34.

Hepatitis C treatment outcomes of African Americans following liver transplantation.

Smallwood GA, Coffey G, Davis L, Martinez E, Stieber AC, Heffron TG.

Transplant Proc. 2002 Dec;34(8):3317-8. No abstract available.

PMID:
12493459
35.

Autoimmune hepatitis following liver transplantation: relationship to recurrent disease and steroid weaning.

Heffron TG, Smallwood GA, Oakley B, Pillen T, Welch D, Martinez E, Romero R, Stieber AC.

Transplant Proc. 2002 Dec;34(8):3311-2. No abstract available.

PMID:
12493456
36.

Can patients awaiting liver transplantation elicit an immune response to the hepatitis A vaccine?

Smallwood GA, Coloura CT, Martinez E, Stieber AC, Heffron TG.

Transplant Proc. 2002 Dec;34(8):3289-90. No abstract available.

PMID:
12493448
37.

Prevalence of depressive symptoms in patients being evaluated for liver transplantation.

Norris ER, Smallwood GA, Connor K, McDonell K, Martinez E, Stieber AC, Heffron TG.

Transplant Proc. 2002 Dec;34(8):3285-6. No abstract available.

PMID:
12493446
38.

Osteoporosis screening in an outpatient liver transplant clinic: impact of primary immunosuppression.

Smallwood GA, Wickman JM, Martinez E, Stieber AC, Heffron TG.

Transplant Proc. 2002 Aug;34(5):1569-70. No abstract available.

PMID:
12176489
39.

Mycophenolate's influence in the treatment of recurrent hepatitis c following liver transplantation.

Smallwood GA, Davis L, Martinez E, Stieber AC, Heffron TG.

Transplant Proc. 2002 Aug;34(5):1559-60. No abstract available.

PMID:
12176484
40.

Renal sparing effects of mycophenolate when used in long-term liver transplant recipients [correction of receipients].

Smallwood G, Stieber A, Davis L, Martinez E, Heffron T.

Transplant Proc. 2002 Aug;34(5):1550. No abstract available.

PMID:
12176479
41.

Sirolimus-based immunosuppressive [correction of immunosuppresive] protocol for calcineurin sparing in liver transplantation.

Heffron TG, Smallwood GA, Davis L, Martinez E, Stieber AC.

Transplant Proc. 2002 Aug;34(5):1522-3. No abstract available.

PMID:
12176466
42.

Liver transplant induction trial of daclizumab to spare calcineurin inhibition.

Heffron TG, Smallwood GA, Pillen T, Davis L, Martinez E, Romero R, Stieber AC.

Transplant Proc. 2002 Aug;34(5):1514-5. No abstract available.

PMID:
12176462
43.

Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation.

De Vera ME, Smallwood GA, Rosado K, Davis L, Martinez E, Sharma S, Stieber AC, Heffron TG.

Transplantation. 2001 Mar 15;71(5):678-86.

PMID:
11292302
44.

Preemptive ganciclovir for CMV viremia in liver transplantation.

Smallwood GA, de Vera ME, Davis L, Martinez E, Stieber AC, Heffron TG.

Transplant Proc. 2001 Feb-Mar;33(1-2):1814-5. No abstract available.

PMID:
11267525
45.

Daclizumab induction in liver transplant recipients.

Heffron TG, Smallwood GA, de Vera ME, Davis L, Martinez E, Stieber AC.

Transplant Proc. 2001 Feb-Mar;33(1-2):1527. No abstract available.

PMID:
11267408
47.

The neuronal Golgi apparatus is fragmented in transgenic mice expressing a mutant human SOD1, but not in mice expressing the human NF-H gene.

Stieber A, Gonatas JO, Collard J, Meier J, Julien J, Schweitzer P, Gonatas NK.

J Neurol Sci. 2000 Feb 1;173(1):63-72.

PMID:
10675581
48.
49.
50.

Environmental factors modulate the size and the secretory activity of the notochord. A study of the Golgi apparatus in avian embryos.

Monsoro-Burq AH, Stieber A, Bontoux M, Le Douarin N, Gonatas NK.

C R Acad Sci III. 1998 Aug;321(8):621-31.

PMID:
9841097

Supplemental Content

Loading ...
Support Center